ResearcherActive in the last 2 years
Tomas Koltai
Matched on ORCID iD 0000-0002-7398-5096; OpenAlex author ID A5024538800. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 7
- Altered Potassium Channels in Pancreatic Ductal Adenocarcinoma: Mechanisms, Implications, and Therapeutic Opportunities Co-author DOI 10.20944/preprints202605.1339.v1↗
- Genetic Signature of Human Pancreatic Cancer and Personalized Targeting. Last author DOI 10.3390/cells13070602↗
- Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its Sensitivity to Gemcitabine and C18-Gemc… Co-author DOI 10.3390/cells13090730↗
- Earlier Diagnosis of Pancreatic Cancer: Is It Possible? Co-author DOI 10.3390/cancers15184430↗
- Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. Co-author DOI 10.3390/cancers14102486↗
- Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as The… Co-author DOI 10.3390/cancers13236135↗
- Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer. Co-author DOI 10.3390/ijms22083953↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stephan J. Reshkin · 5 shared papers, 2021–2024 · strength 1.06
- Paper Genetic Signature of Human Pancreatic Cancer and Personalized Targeting. DOI 10.3390/cells13070602↗
- Paper Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer. DOI 10.3390/ijms22083953↗
- Paper Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its… DOI 10.3390/cells13090730↗
- Rosa Angela Cardone · 5 shared papers, 2021–2024 · strength 1.06
- Paper Genetic Signature of Human Pancreatic Cancer and Personalized Targeting. DOI 10.3390/cells13070602↗
- Paper Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer. DOI 10.3390/ijms22083953↗
- Paper Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its… DOI 10.3390/cells13090730↗
- Tiago M. A. Carvalho · 4 shared papers, 2021–2024 · strength 0.70
- Paper Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer. DOI 10.3390/ijms22083953↗
- Paper Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its… DOI 10.3390/cells13090730↗
- Paper Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. DOI 10.3390/cancers14102486↗
- Maria Raffaella Greco · 3 shared papers, 2021–2024 · strength 0.51
- Paper Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its… DOI 10.3390/cells13090730↗
- Paper Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. DOI 10.3390/cancers14102486↗
- Paper Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physic… DOI 10.3390/cancers13236135↗
- Silvia Arpicco · 1 shared paper, 2024 · strength 0.18
- Natalia B. Prevarskaya · 1 shared paper, 2024 · strength 0.18
- Madelaine Magalì Audero · 1 shared paper, 2024 · strength 0.18
- Alessandra Fiorio Pla · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.